Additionally, our previous study showed that G9a inhibitor and some LSD1 inhibitors could protect against ototoxic drug–induced HC death, suggesting that epigenetic mechanisms are involved in ototoxic drug–induced hearing loss.33, 34. This evidence concerns the gene KDM1A and hearing loss disorder.